Asston Pharmaceuticals IPO

About Asston Pharmaceuticals IPO

Asston Pharmaceuticals IPO is a book-built issue worth ₹27.56 crore. The IPO consists entirely of a fresh issue of 22.41 lakh equity shares. The IPO opens for subscription on July 9, 2025, and closes on July 11, 2025. The allotment is expected to be finalised on July 14, 2025, with tentative listing on BSE SME scheduled for July 16, 2025.

The IPO is priced in a band of ₹115 – ₹123 per share. Retail investors must apply for a minimum of 2 lots comprising 2,000 shares, requiring an investment of ₹2,46,000 at the upper end of the price band. HNI investors must apply for a minimum of 3 lots (3,000 shares), amounting to ₹3,69,000.

Sobhagya Capital Options Ltd is the book-running lead manager to the issue, and Maashitla Securities Private Limited is the registrar.

For detailed information on company financials, business operations, and associated risks, investors are advised to refer to the Asston Pharmaceuticals IPO RHP.

Industry Outlook

1. India’s electricity infrastructure is undergoing a transformative shift, driven by the government’s ambitious push towards smart metering and grid modernisation. This evolution is central to enhancing energy efficiency, reducing transmission losses, and improving billing transparency across the power distribution network.
2. The National Smart Grid Mission (NSGM) and the Revamped Distribution Sector Scheme (RDSS) are pivotal government initiatives aimed at deploying 250 million smart meters by 2027. As of January 2024, only 3.02 million smart meters had been installed, indicating substantial headroom for growth. These programmes are not only modernising the grid but also fostering a robust ecosystem involving manufacturers, system integrators, and service providers.
3. The competitive landscape is dynamic, with global giants such as Siemens, Schneider Electric, and L&T dominating the high-value transmission and distribution segments. Simultaneously, domestic players like Genus Power and HPL Electric are gaining traction in the smart meter manufacturing space, leveraging the “Make in India” initiative to offer cost-effective solutions. This has led to a fragmented yet vibrant market where cost competitiveness, technological innovation, and strategic partnerships are key differentiators.
4. System integrators and technology providers play a crucial role in ensuring seamless deployment and integration of smart metering infrastructure. Their ability to manage complex networks and deliver reliable data analytics is becoming increasingly vital.

Asston Pharmaceuticals IPO Objectives

The company proposes to utilise the net proceeds from the IPO for the following objectives:

1. Expand manufacturing infrastructure by establishing new production facilities for its Nutraceutical and Veterinary Food divisions in Palghar, Maharashtra. This includes the acquisition of land, construction of factory premises, and installation of advanced machinery to enhance production capacity and support the company’s growing product portfolio.
2. Strengthen its Homecare and Cosmetic division through the purchase of specialised equipment, enabling the company to diversify its offerings and improve operational efficiency across multiple product categories.
3. Support general corporate purposes, including administrative overheads, brand development, and strategic initiatives aimed at reinforcing the company’s market presence and long-term sustainability.
4. Enhance corporate visibility and governance standards through public listing on NSE Emerge, thereby fostering investor confidence, improving access to capital markets, and facilitating future growth opportunities through strategic partnerships and collaborations.

About Asston Pharmaceuticals Limited

Asston Pharmaceuticals Limited was originally incorporated as Asston Pharmaceuticals Private Limited on 18 September 2002 under the Companies Act, 1956. It was subsequently converted into a public limited company and renamed Asston Pharmaceuticals Limited on 19 June 2024.

The company is engaged in the manufacturing of electronic energy meters and power conditioning devices, including high-grade chargers and uninterruptible power supply (UPS) systems. Its products cater to a wide range of institutional, industrial, and utility customers across India.

With a strong emphasis on quality and performance, Eppeltone operates a dedicated manufacturing facility in Greater Noida, Uttar Pradesh. The company has developed a reputation for delivering high-precision, reliable metering solutions, and has secured approvals from over 30 state electricity distribution companies (DISCOMs) and several central public sector undertakings.

Eppeltone’s operations are primarily focused within India, with a significant presence in states such as Gujarat, Uttar Pradesh, Madhya Pradesh, Chhattisgarh, and Delhi. The company’s growth strategy is underpinned by its commitment to technological advancement, operational excellence, and customer satisfaction.

By leveraging its established industry credentials and expanding production capabilities, Asston Pharmaceuticals Limited aims to strengthen its position in the smart metering and power electronics sector, capitalising on the growing demand for energy efficiency and digital infrastructure in India’s power distribution landscape.

How To Check the Allotment Status of the Asston Pharmaceuticals IPO?

Steps to check IPO allotment status on Angel One’s app:

1. Log in to the Angel One app.
2. Go to the IPO Section and then to IPO Orders.
3. Select the individual IPO that you had applied for and check the allotment status.
4. Angel One will notify you of your IPO allotment status via push notification and email.

How To Apply for Asston Pharmaceuticals IPO Online?

1. Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
2. Locate the IPO Section: Navigate to the 'IPO' section on the platform.
3. Select IPO: Find and select the Asston Pharmaceuticals IPO from the list of open IPOs.
4. Enter the Lot Size: Specify the number of lots you want to bid for.
5. Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
6. Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.